F-box/LRR-repeat protein 4
F-box protein FBL5 (227-255) is a synthetic peptide fragment derived from the FBL5 protein, a member of the F-box protein family known for its role in the ubiquitin-proteasome pathway. This peptide encompasses amino acid residues 227 to 255 of the parent protein, representing a functionally significant region that may participate in substrate recognition or protein-protein interactions within SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complexes. As a research tool, the fragment offers a focused approach for dissecting the molecular functions and regulatory mechanisms associated with FBL5, enabling detailed exploration of its contribution to protein turnover, cell cycle control, and signal transduction pathways.
Protein-protein interaction studies: The FBL5 (227-255) peptide can be utilized to investigate specific interaction domains within the F-box protein family. By serving as a molecular probe in binding assays such as pull-down experiments, surface plasmon resonance, or co-immunoprecipitation, the fragment allows researchers to map contact sites between FBL5 and its binding partners, including SKP1, substrates, or regulatory proteins. These insights are critical for elucidating the determinants of substrate specificity and the assembly of multi-protein E3 ligase complexes.
Ubiquitination pathway research: As FBL5 is implicated in targeting proteins for ubiquitin-mediated degradation, the synthetic peptide provides a valuable tool for examining the mechanistic basis of substrate recruitment and recognition. In vitro assays employing this fragment can help delineate the minimal regions required for substrate engagement, inform the design of competitive inhibitors, or facilitate the reconstitution of partial SCF complexes. Such studies advance understanding of proteostasis and the selective turnover of key regulatory proteins.
Peptide-based inhibitor development: The defined sequence of FBL5 (227-255) enables its use in the rational design and screening of peptide-based inhibitors that modulate F-box protein interactions. By mimicking or competitively blocking critical binding motifs, the peptide serves as a template for developing molecules that disrupt SCF complex assembly or function. This application is particularly relevant for probing the regulatory nodes of ubiquitin ligase activity and exploring potential avenues for chemical biology research.
Antibody generation and epitope mapping: The unique amino acid sequence of the FBL5 (227-255) fragment makes it an effective immunogen for producing polyclonal or monoclonal antibodies specific to this region of FBL5. Such antibodies are valuable reagents for immunodetection, immunoprecipitation, or localization studies, supporting the identification and quantification of endogenous or recombinant FBL5 in cellular and biochemical contexts. Additionally, the peptide can be used to map antibody epitopes, refining the specificity and utility of immunological tools.
Structural and conformational analysis: The isolated peptide fragment facilitates biophysical studies aimed at characterizing the secondary structure, folding properties, or dynamic behavior of the FBL5 protein's C-terminal region. Techniques such as circular dichroism spectroscopy, NMR, or crystallography can be employed to assess how this segment contributes to the overall architecture of the protein, its interaction surfaces, or its conformational flexibility. These structural insights are essential for correlating sequence features with function and for informing structure-guided research initiatives.
Collectively, the FBL5 (227-255) peptide offers a versatile platform for advancing research in protein ubiquitination, molecular recognition, and targeted modulation of cellular pathways. Its defined sequence and functional relevance make it a valuable addition to the toolkit of researchers investigating the mechanistic underpinnings of F-box protein biology and the broader landscape of post-translational regulation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.